Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2018 | Review article

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system

Author: Karl Messlinger

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

Calcitonin gene-related peptide (CGRP) has long been a focus of migraine research, since it turned out that inhibition of CGRP or CGRP receptors by antagonists or monoclonal IgG antibodies was therapeutic in frequent and chronic migraine. This contribution deals with the questions, from which sites CGRP is released, where it is drained and where it acts to cause its headache proliferating effects in the trigeminovascular system.

Results

The available literature suggests that the bulk of CGRP is released from trigeminal afferents both in meningeal tissues and at the first synapse in the spinal trigeminal nucleus. CGRP may be drained off into three different compartments, the venous blood plasma, the cerebrospinal fluid and possibly the glymphatic system. CGRP receptors in peripheral tissues are located on arterial vessel walls, mononuclear immune cells and possibly Schwann cells; within the trigeminal ganglion they are located on neurons and glial cells; in the spinal trigeminal nucleus they can be found on central terminals of trigeminal afferents. All these structures are potential signalling sites for CGRP, where CGRP mediates arterial vasodilatation but not direct activation of trigeminal afferents. In the spinal trigeminal nucleus a facilitating effect on synaptic transmission seems likely. In the trigeminal ganglion CGRP is thought to initiate long-term changes including cross-signalling between neurons and glial cells based on gene expression. In this way, CGRP may upregulate the production of receptor proteins and pro-nociceptive molecules.

Conclusions

CGRP and other big molecules cannot easily pass the blood-brain barrier. These molecules may act in the trigeminal ganglion to influence the production of pronociceptive substances and receptors, which are transported along the central terminals into the spinal trigeminal nucleus. In this way peripherally acting therapeutics can have a central antinociceptive effect.

Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53. https://doi.org/10.1038/nrn1824.CrossRefPubMed

Amara SG, Jonas V, Rosenfeld MG et al (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240–244.CrossRefPubMed

Aspelund A, Antila S, Proulx ST et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991–999. https://doi.org/10.1084/jem.20142290.CrossRefPubMedPubMedCentral

Bellamy J, Bowen EJ, Russo AF, Durham PL (2006) Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23:2057–2066. https://doi.org/10.1111/j.1460-9568.2006.04742.x.CrossRefPubMedPubMedCentral

Buldyrev I, Tanner NM, Hsieh H et al (2006) Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem 99:1338–1350. https://doi.org/10.1111/j.1471-4159.2006.04161.x.CrossRefPubMedPubMedCentral

Covasala O, Stirn SL, Albrecht S et al (2012) Calcitonin gene-related peptide receptors in rat trigeminal ganglion do not control spinal trigeminal activity. J Neurophysiol 108:431–440. https://doi.org/10.1152/jn.00167.2011.CrossRefPubMed

Dieterle A, Fischer MJM, Link AS et al (2011) Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor. Cephalalgia Int J. Headache 31:31–42. https://doi.org/10.1177/0333102410375725.

Dux M, Will C, Eberhardt M et al (2017) Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow. Neuropeptides 64:61–68. https://doi.org/10.1016/j.npep.2017.02.080.CrossRefPubMed

Eberhardt M, Hoffmann T, Sauer SK et al (2008) Calcitonin gene-related peptide release from intact isolated dorsal root and trigeminal ganglia. Neuropeptides 42:311–317. https://doi.org/10.1016/j.npep.2008.01.002.CrossRefPubMed

10.

Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89:901–907.CrossRefPubMed

11.

Edvinsson L, Ekman R, Jansen I et al (1987) Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 7:720–728. https://doi.org/10.1038/jcbfm.1987.126.CrossRef

12.

Edvinsson L, Fredholm BB, Hamel E et al (1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58:213–217.CrossRefPubMed

13.

Edvinsson L, Goadsby PJ (1995) Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia Int J Headache 15:272–276. https://doi.org/10.1046/j.1468-2982.1995.1504272.x.CrossRef

14.

Edvinsson L, Jansen I, Cunha e Sa M, Gulbenkian S (1994) Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries. Cephalalgia Int J Headache 14:88–96CrossRef

15.

Eftekhari S, Edvinsson L (2011) Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 12:112. https://doi.org/10.1186/1471-2202-12-112.CrossRefPubMedPubMedCentral

16.

Eftekhari S, Gaspar RC, Roberts R et al (2016) Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: a detailed study using in situ hybridization, immunofluorescence, and autoradiography. J Comp Neurol 524:90–118. https://doi.org/10.1002/cne.23828.CrossRefPubMed

17.

Eftekhari S, Salvatore CA, Calamari A et al (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169:683–696. https://doi.org/10.1016/j.neuroscience.2010.05.016.CrossRefPubMed

18.

Eftekhari S, Salvatore CA, Johansson S et al (2015) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Brain Res 1600:93–109. https://doi.org/10.1016/j.brainres.2014.11.031.CrossRefPubMed

19.

Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain Off J Am Pain Soc 14:1289–1303. https://doi.org/10.1016/j.jpain.2013.03.010.CrossRef

20.

Fabbretti E, D’Arco M, Fabbro A et al (2006) Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26:6163–6171. https://doi.org/10.1523/JNEUROSCI.0647-06.2006.CrossRefPubMed

21.

Fischer MJM, Koulchitsky S, Messlinger K (2005) The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 25:5877–5883. https://doi.org/10.1523/JNEUROSCI.0869-05.2005.CrossRefPubMed

22.

Garraway SM, Huie JR (2016) Spinal plasticity and behavior: BDNF-induced Neuromodulation in uninjured and injured spinal cord. Neural Plast 2016:9857201. doi: https://doi.org/10.1155/2016/9857201.

23.

Gupta S, Amrutkar DV, Mataji A et al (2010) Evidence for CGRP re-uptake in rat dura mater encephali. Br J Pharmacol 161:1885–1898. https://doi.org/10.1111/j.1476-5381.2010.01012.x.CrossRefPubMedPubMedCentral

24.

Hoffmann J, Wecker S, Neeb L et al (2012) Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF. Cephalalgia Int J Headache 32:659–667. https://doi.org/10.1177/0333102412447701.CrossRef

25.

Iliff JJ, Goldman SA, Nedergaard M (2015) Implications of the discovery of brain lymphatic pathways. Lancet Neurol 14:977–979. https://doi.org/10.1016/S1474-4422(15)00221-5.CrossRefPubMedPubMedCentral

26.

Iliff JJ, Lee H, Yu M et al (2013) Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 123:1299–1309. https://doi.org/10.1172/JCI67677.CrossRefPubMedPubMedCentral

27.

Jansen-Olesen I, Mortensen A, Edvinsson L (1996) Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia Int J Headache 16:310–316.CrossRef

28.

Juaneda C, Dumont Y, Quirion R (2000) The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 21:432–438CrossRefPubMed

29.

Kageneck C, Nixdorf-Bergweiler BE, Messlinger K, Fischer MJ (2014) Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate. J Headache Pain 15:7. https://doi.org/10.1186/1129-2377-15-7.CrossRefPubMedPubMedCentral

30.

Lee Y, Kawai Y, Shiosaka S et al (1985) Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis. Brain Res 330:194–196.CrossRefPubMed

31.

Lennerz JK, Rühle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277–1299. https://doi.org/10.1002/cne.21607.CrossRefPubMed

32.

Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698–705. https://doi.org/10.1002/ana.20619.CrossRefPubMed

33.

Levy D, Strassman AM (2002) Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol 538:483–493.CrossRefPubMedPubMedCentral

34.

Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32. https://doi.org/10.1016/j.brainres.2007.12.028.CrossRefPubMedPubMedCentral

35.

Mason RT, Peterfreund RA, Sawchenko PE et al (1984) Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature 308:653–655.CrossRefPubMed

36.

McCulloch J, Uddman R, Kingman TA, Edvinsson L (1986) Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 83:5731–5735.CrossRefPubMedPubMedCentral

37.

Messlinger K, Fischer MJM, Lennerz JK (2011) Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60:82–89.CrossRefPubMed

38.

Messlinger K, Hanesch U, Baumgärtel M et al (1993) Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol (Berl) 188:219–237.CrossRef

39.

Ottosson A, Edvinsson L (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia Int J Headache 17:166–174. https://doi.org/10.1046/j.1468-2982.1997.1703166.x.CrossRef

40.

Ray BS, Wolff HG (1940) Experimental studies on headache: pain sensitive structures of the head and their significance in headache. Arch Surg 1:813–856.CrossRef

41.

Rosenfeld MG, Mermod JJ, Amara SG et al (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129–135.CrossRefPubMed

42.

Russell FA, King R, Smillie S-J et al (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94:1099–1142. https://doi.org/10.1152/physrev.00034.2013.CrossRefPubMedPubMedCentral

43.

Schaible HG, Ebersberger A, Peppel P et al (1997) Release of immunoreactive substance P in the trigeminal brain stem nuclear complex evoked by chemical stimulation of the nasal mucosa and the dura mater encephali--a study with antibody microprobes. Neuroscience 76:273–284.CrossRefPubMed

44.

Schain AJ, Melo-Carrillo A, Strassman AM, Burstein R (2017) Cortical spreading depression closes Paravascular space and impairs Glymphatic flow: implications for migraine headache. J Neurosci 37:2904–2915. https://doi.org/10.1523/JNEUROSCI.3390-16.2017.CrossRefPubMedPubMedCentral

45.

Schwenger N, Dux M, de Col R et al (2007) Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia Int J Headache 27:481–491. https://doi.org/10.1111/j.1468-2982.2007.01321.x.CrossRef

46.

Seiler K, Nusser JI, Lennerz JK et al (2013) Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment. J Headache Pain 14:74. https://doi.org/10.1186/1129-2377-14-74.CrossRefPubMedPubMedCentral

47.

Sekiguchi T, Kuwasako K, Ogasawara M et al (2016) Evidence for conservation of the Calcitonin Superfamily and activity-regulating mechanisms in the basal chordate Branchiostoma floridae: insights into the molecular and functional evolution in chordates. J Biol Chem 291:2345–2356. https://doi.org/10.1074/jbc.M115.664003.CrossRefPubMed

48.

Simonetti M, Giniatullin R, Fabbretti E (2008) Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem 283:18743–18752. https://doi.org/10.1074/jbc.M800296200.CrossRefPubMed

49.

Storer RJ, Akerman S, Goadsby PJ (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142:1171–1181. https://doi.org/10.1038/sj.bjp.0705807.CrossRefPubMedPubMedCentral

50.

Takhshid MA, Owji AA, Panjehshahin MR (2007) In vitro effects of adrenomedullin and calcitonin gene related peptide on the release of serotonin and amino acids from rat dorsal spinal cord. Neurosci Lett 420:193–197. https://doi.org/10.1016/j.neulet.2007.03.061.CrossRefPubMed

51.

Tarasoff-Conway JM, Carare RO, Osorio RS et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11:457–470. https://doi.org/10.1038/nrneurol.2015.119.CrossRefPubMedPubMedCentral

52.

Uddman R, Edvinsson L, Ekman R et al (1985) Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62:131–136.CrossRefPubMed

53.

Wiesenfeld-Hallin Z, Hökfelt T, Lundberg JM et al (1984) Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett 52:199–204.CrossRefPubMed

54.

Will C, Messlinger K, Fischer MJM (2016) Vessel diameter measurements at the medullary brainstem in vivo as an index of trigeminal activity. Brain Res 1632:51–57. https://doi.org/10.1016/j.brainres.2015.12.013.CrossRefPubMed

55.

Zhang ET, Inman CB, Weller RO (1990) Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat 170:111–123.PubMedPubMedCentral

Title: The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
Author: Karl Messlinger
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0848-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system

Abstract

Background

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine

Evaluation of gray matter perfusion in episodic migraine using voxel-wise comparison of 3D pseudo-continuous arterial spin labeling

Poor sleep quality in migraine and probable migraine: a population study

Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro